RETRACTION

Pathol. Oncol. Res., 28 March 2024

Volume 30 - 2024 | https://doi.org/10.3389/pore.2024.1611767

Retraction: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2

Article metrics

1,1k

Views

676

Downloads

Following publication, concerns were raised on the PubPeer platform regarding the validity of the data in the article. An investigation by the Editorial Office, conducted in accordance with Pathology and Oncology Research policies, was unable to confirm the validity of the data presented and as such cannot confirm its reliability. The article is therefore retracted.

This retraction was approved by the Editor-in-Chief of Pathology and Oncology Research. The authors received communication regarding the retraction but did not respond. The communication has been recorded by the publisher.

Pathology and Oncology Research would like to thank the concerned reader who contacted us regarding the published article.

Summary

Keywords

Glioblastoma, miR-184, STC2, proliferation, Migration, invasion

Citation

Pathology & Oncology Research Editorial Office (2024) Retraction: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2. Pathol. Oncol. Res. 30:1611767. doi: 10.3389/pore.2024.1611767

Received

14 March 2024

Accepted

14 March 2024

Published

28 March 2024

Approved by

József Tímár, Semmelweis University, Hungary

Volume

30 - 2024

Updates

Copyright

*Correspondence: Pathology & Oncology Research Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article